Article Details

AstraZeneca and Merck Receives European Commission Approval For Expanded Use ... - Benzinga

Retrieved on: 2022-08-04 15:21:34

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca and Merck Receives European Commission Approval For Expanded Use ... - Benzinga. View article details on HISWAI: https://www.benzinga.com/general/health-care/22/08/28358009/astrazeneca-and-merck-receives-european-commission-approval-for-expanded-use-in-breast-cancer

Excerpt

The European Commission (EC) has approved AstraZeneca (NASDAQ: AZN) and Merck's (NYSE: MRK) LYNPARZA as monotherapy or in combination with ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up